Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Bayer
Samsung Medical Center
Aurigene Discovery Technologies Limited
Pfizer
Memorial Sloan Kettering Cancer Center
IDEAYA Biosciences
Debiopharm International SA
University of Pittsburgh
Orano Med LLC
Beijing Biotech
A2 Biotherapeutics Inc.
Chung Shan Medical University
University of Kansas Medical Center
DualityBio Inc.
First Affiliated Hospital of Ningbo University
Calico Life Sciences LLC
SciTech Development, Inc.
Memorial Sloan Kettering Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Incyte Corporation
Shanghai Pulmonary Hospital, Shanghai, China
Second Life Therapeutics
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Blanco, Dr Antonio Calles MD
Biogen
Shanghai Chest Hospital
University Hospital Southampton NHS Foundation Trust
A2 Biotherapeutics Inc.
Faeth Therapeutics
Biomea Fusion Inc.
Stanford University
Bristol-Myers Squibb
Sun Yat-sen University
Anaveon AG
Molecular Templates, Inc.
Dana-Farber Cancer Institute
Mundipharma Research Limited
Shanghai Pulmonary Hospital, Shanghai, China
National Cancer Institute (NCI)
Shanghai Jiao Tong University School of Medicine
National Cancer Institute (NCI)
Augusta University
Chang Gung Memorial Hospital
Peking University Third Hospital
University of Kansas Medical Center
Pfizer
H. Lee Moffitt Cancer Center and Research Institute